Lek extends antibiotics production in Prevalje plant
Prevalje, 31 August - Pharma company Lek has again extended antibiotics production in its Prevalje production facility after several postponements since October 2019. The Ljubljana-based company was to phase out antibiotics production in Prevalje by September, but its owner Novartis decided to make adjustments due to global demand for antibiotics.
The rest of this news item is available to subscribers.
The news item consists of 832 characters (without spaces) or 165 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.